+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Neonatal Genetic Disease Diagnosis Market - Global Forecast 2026-2032- Product Image
Neonatal Genetic Disease Diagnosis Market - Global Forecast 2026-2032- Product Image
Sale

Neonatal Genetic Disease Diagnosis Market - Global Forecast 2026-2032

  • Report

  • 188 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6146508
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Neonatal Genetic Disease Diagnosis Market is projected to reach USD 2.71 Billion in 2026. It is expected to continue growing at a CAGR of 8.98%, reaching USD 4.60 Billion by 2032.

Neonatal Genetic Disease Diagnosis: Executive Overview

Neonatal genetic disease diagnosis encompasses screening, confirmatory testing, and clinical interpretation used to identify inherited conditions shortly after birth. Its importance is increasing as genomic technologies, biochemical assays, and multidisciplinary care pathways improve the ability to detect disorders before symptoms become irreversible. Effective programs combine validated testing with parental counseling, confirmatory evaluation, referral pathways, and access to early treatment.

Screening Is Shifting Toward Earlier, More Integrated Care

The field is moving from isolated condition-specific testing toward coordinated diagnostic pathways that link newborn screening, rapid molecular testing, clinical assessment, and longitudinal follow-up. Wider use of next-generation sequencing is expanding the range of detectable variants, while improvements in laboratory automation and data interpretation are supporting faster turnaround. Key implementation challenges remain, including variant interpretation, false-positive management, informed consent, equitable access, and the need to connect test results with specialized clinical services.

Artificial Intelligence Is Strengthening Interpretation and Workflow

Artificial intelligence is contributing to neonatal genetic disease diagnosis through variant prioritization, phenotype matching, image and waveform analysis, quality control, and workflow triage. Its greatest practical value is cumulative: it can help laboratories manage complex datasets, assist clinicians in recognizing patterns, and reduce manual review burdens when integrated with validated protocols. Human oversight remains essential because neonatal presentations are often nonspecific, training data may be uneven across populations, and algorithmic outputs require clinical confirmation and appropriate governance.

Regional Differences Reflect Health-System Capacity and Policy

North America is characterized by established newborn-screening infrastructure, advanced genomic services, and growing interest in rapid testing for critically ill infants. Europe benefits from strong public-health institutions and cross-border scientific collaboration, although screening panels, reimbursement, and consent requirements vary. Asia-Pacific combines advanced capabilities in economies such as Australia, Japan, and South Korea with substantial access differences across the wider region. Latin America is expanding laboratory and referral capacity but continues to face geographic and resource constraints. The Middle East is developing specialized genomic programs alongside national health-system modernization. Africa has important opportunities to improve early diagnosis, yet limited laboratory infrastructure, workforce shortages, and underrepresentation in reference datasets remain significant barriers.

Major Multilateral Groups Can Align Standards and Access

ASEAN cooperation can support shared laboratory standards, referral networks, and workforce development across diverse health systems. BRICS countries can advance collaboration on affordable sequencing, local manufacturing, data resources, and capacity building while accounting for different regulatory environments. The European Union can strengthen interoperability, cross-border referral, and common approaches to data governance. G7 members can contribute to evidence standards, responsible artificial-intelligence practices, and global technical assistance. GCC states can coordinate specialized services, screening policies, and genomic data stewardship. NATO members may benefit from interoperable emergency and laboratory capabilities, particularly where neonatal diagnosis intersects with resilience planning and cross-border health preparedness.

Country Priorities Range from Program Expansion to Equity

Australia can build on coordinated screening and genomic expertise while improving access across remote communities. Brazil and Mexico face opportunities to strengthen regional referral networks, laboratory capacity, and follow-up in geographically dispersed populations. Canada and the United States can continue integrating rapid genomic testing with critical-care pathways and improve representation in genomic datasets. China, India, Russia, and South Korea are positioned to expand domestic laboratory capabilities while addressing population diversity, regulatory consistency, and access outside major centers. France, Germany, Italy, Spain, and the United Kingdom can further align screening policies, reimbursement, data governance, and cross-border clinical pathways within Europe. Japan can continue advancing precision diagnostics, quality assurance, and specialist coordination for neonatal care.

Priorities for Leaders: Link Testing to Timely Clinical Action

Industry leaders should design services around the full diagnostic pathway rather than the test alone. Priorities include validating assays in representative populations, publishing transparent performance metrics, establishing rapid confirmatory pathways, and embedding genetic counseling into care delivery. Organizations should invest in interoperable laboratory and clinical data systems, develop clear artificial-intelligence governance, and monitor disparities in access and outcomes. Partnerships with hospitals, public-health agencies, patient organizations, and academic centers can improve implementation, while workforce programs should address shortages in laboratory genetics, bioinformatics, counseling, and neonatal specialty care.

Methodology: Evidence-Based Synthesis of Diagnostic Practice

This executive summary uses a structured qualitative synthesis of established developments in neonatal genetic disease diagnosis, including screening practice, genomic testing, laboratory operations, clinical integration, artificial-intelligence applications, policy considerations, and health-system capacity. Insights are organized across the specified regions, country groups, and countries. The assessment emphasizes documented clinical and operational trends, avoids unsupported numerical claims, and distinguishes technology potential from validated clinical utility. Interpretation should be complemented by current national guidelines, regulatory decisions, peer-reviewed evidence, and local implementation data.

Conclusion: Earlier Diagnosis Requires Integrated, Equitable Systems

Neonatal genetic disease diagnosis is progressing toward faster, broader, and more connected care. Genomic technologies and artificial intelligence can improve detection and interpretation, but their impact depends on confirmation, counseling, specialist access, responsible data use, and equitable implementation. Leaders that combine technical validation with robust clinical pathways and regional collaboration will be better positioned to translate earlier diagnosis into meaningful outcomes for newborns and families.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Neonatal Genetic Disease Diagnosis Market, by Technology
7.1. Introduction
7.2. Microarrays
7.2.1. Cgh Array
7.2.2. Snp Array
7.3. Pcr
7.3.1. Digital Pcr
7.3.2. Qpcr
7.4. Sequencing
7.4.1. Ngs
7.4.2. Sanger
8. Neonatal Genetic Disease Diagnosis Market, by Disease Type
8.1. Introduction
8.2. Chromosomal Abnormality
8.3. Metabolic Disorder
8.4. Single Gene Disorder
9. Neonatal Genetic Disease Diagnosis Market, by Testing Mode
9.1. Introduction
9.2. Invasive
9.3. Non Invasive
10. Neonatal Genetic Disease Diagnosis Market, by Sample Type
10.1. Introduction
10.2. Amniotic Fluid
10.3. Blood
10.4. Tissue
10.5. Umbilical Cord Blood
11. Neonatal Genetic Disease Diagnosis Market, by End User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Hospitals
11.4. Research Institutes
12. Neonatal Genetic Disease Diagnosis Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Neonatal Genetic Disease Diagnosis Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Neonatal Genetic Disease Diagnosis Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agilent Technologies, Inc.
16.2. Baylor Genetics
16.3. BGI Genomics Co., Ltd.
16.4. Bio-Rad Laboratories, Inc.
16.5. Danaher Corporation
16.6. F. Hoffmann-La Roche Ltd.
16.7. Fulgent Genetics, Inc.
16.8. GeneDx Holdings Corp.
16.9. Guardant Health, Inc.
16.10. Illumina, Inc.
16.11. Invitae Corporation
16.12. Laboratory Corporation of America Holdings
16.13. Natera, Inc.
16.14. Oxford Nanopore Technologies plc
16.15. Personalis, Inc.
16.16. Quest Diagnostics Incorporated
16.17. Sophia Genetics SA
16.18. The Children's Hospital of Philadelphia
16.19. Thermo Fisher Scientific Inc.
16.20. Twist Bioscience Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Neonatal Genetic Disease Diagnosis Market, Years Considered for the Study
FIGURE 2. Global Neonatal Genetic Disease Diagnosis Market, Research Design
FIGURE 3. Global Neonatal Genetic Disease Diagnosis Market, Research Framework
FIGURE 4. Global Neonatal Genetic Disease Diagnosis Market, Data Triangulation
FIGURE 5. Global Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 7. Global Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2025 vs 2032 (%)
FIGURE 9. Global Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2025 vs 2032 (%)
FIGURE 11. Global Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 13. Global Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Neonatal Genetic Disease Diagnosis Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Neonatal Genetic Disease Diagnosis Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Neonatal Genetic Disease Diagnosis Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Neonatal Genetic Disease Diagnosis Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Neonatal Genetic Disease Diagnosis Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Neonatal Genetic Disease Diagnosis Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Neonatal Genetic Disease Diagnosis Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Neonatal Genetic Disease Diagnosis Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Neonatal Genetic Disease Diagnosis Market Segmentation & Coverage
TABLE 2. Global Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 3. Global Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 4. Global Microarrays Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Microarrays Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Microarrays Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Cgh Array Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Cgh Array Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Cgh Array Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Snp Array Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Snp Array Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Snp Array Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Digital Pcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Digital Pcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Digital Pcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Qpcr Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Qpcr Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Qpcr Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Ngs Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Ngs Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Ngs Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Sanger Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Sanger Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Sanger Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 32. Global Chromosomal Abnormality Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Chromosomal Abnormality Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Chromosomal Abnormality Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Metabolic Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Metabolic Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Metabolic Disorder Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Single Gene Disorder Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Single Gene Disorder Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Single Gene Disorder Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 42. Global Invasive Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Invasive Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Invasive Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Non Invasive Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Global Non Invasive Market Size, by Group, 2017-2032 (USD Million)
TABLE 47. Global Non Invasive Market Size, by Country, 2017-2032 (USD Million)
TABLE 48. Global Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 49. Global Amniotic Fluid Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Amniotic Fluid Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Amniotic Fluid Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Umbilical Cord Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Umbilical Cord Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Umbilical Cord Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 62. Global Diagnostic Laboratories Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Diagnostic Laboratories Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Diagnostic Laboratories Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 79. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 80. Asia-Pacific Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 81. North America Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. North America Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 83. North America Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 84. North America Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 85. North America Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 86. North America Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 87. North America Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 88. North America Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 89. North America Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 90. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 91. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 92. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 93. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 94. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 95. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 96. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 97. Latin America Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 98. Latin America Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Europe Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Europe Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 101. Europe Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 102. Europe Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 103. Europe Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 104. Europe Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 105. Europe Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 106. Europe Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 107. Europe Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 110. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 111. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 112. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 113. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 114. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 115. Middle East Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 116. Middle East Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. Africa Neonatal Genetic Disease Diagnosis Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Africa Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 119. Africa Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 120. Africa Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 121. Africa Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 122. Africa Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 123. Africa Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 124. Africa Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 125. Africa Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 126. Global Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 129. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 130. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 131. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 132. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 133. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 134. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 135. ASEAN Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. GCC Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. GCC Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 138. GCC Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 139. GCC Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 140. GCC Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 141. GCC Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 142. GCC Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 143. GCC Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 144. GCC Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. European Union Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 146. European Union Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 147. European Union Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 148. European Union Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 149. European Union Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 150. European Union Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 151. European Union Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 152. European Union Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 153. European Union Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 154. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 155. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 156. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 157. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 158. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 159. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 160. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 161. BRICS Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 162. BRICS Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 163. G7 Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 164. G7 Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. G7 Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 166. G7 Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 167. G7 Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 168. G7 Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 169. G7 Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 170. G7 Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 171. G7 Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. NATO Neonatal Genetic Disease Diagnosis Market Size, by Group, 2017-2032 (USD Million)
TABLE 173. NATO Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 174. NATO Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 175. NATO Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 176. NATO Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 177. NATO Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 178. NATO Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 179. NATO Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 180. NATO Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 181. Global Neonatal Genetic Disease Diagnosis Market Size, by Country, 2017-2032 (USD Million)
TABLE 182. United States Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 183. United States Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 184. United States Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 185. United States Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 186. United States Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 187. United States Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 188. United States Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 189. United States Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 190. United States Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 191. Canada Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 192. Canada Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 193. Canada Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 194. Canada Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 195. Canada Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 196. Canada Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 197. Canada Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 198. Canada Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 199. Canada Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. Mexico Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 201. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 202. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 203. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 204. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 205. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 206. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 207. Mexico Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 208. Mexico Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 209. Brazil Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 210. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 211. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 212. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 213. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 214. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 215. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 216. Brazil Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 217. Brazil Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 218. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 219. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 220. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 221. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 222. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 223. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 224. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 225. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 226. United Kingdom Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 227. Germany Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 228. Germany Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 229. Germany Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 230. Germany Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 231. Germany Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 232. Germany Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 233. Germany Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 234. Germany Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 235. Germany Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 236. France Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 237. France Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 238. France Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 239. France Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 240. France Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 241. France Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 242. France Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 243. France Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 244. France Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Russia Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 246. Russia Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 247. Russia Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 248. Russia Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 249. Russia Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 250. Russia Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 251. Russia Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 252. Russia Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 253. Russia Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. Italy Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 255. Italy Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 256. Italy Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 257. Italy Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 258. Italy Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 259. Italy Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 260. Italy Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 261. Italy Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 262. Italy Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Spain Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 264. Spain Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 265. Spain Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 266. Spain Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 267. Spain Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 268. Spain Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 269. Spain Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 270. Spain Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 271. Spain Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 272. China Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 273. China Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 274. China Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 275. China Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 276. China Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 277. China Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 278. China Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 279. China Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 280. China Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 281. India Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 282. India Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 283. India Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 284. India Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 285. India Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 286. India Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 287. India Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 288. India Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 289. India Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. Japan Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 291. Japan Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 292. Japan Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 293. Japan Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 294. Japan Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 295. Japan Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 296. Japan Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 297. Japan Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 298. Japan Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. Australia Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 300. Australia Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 301. Australia Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 302. Australia Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 303. Australia Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 304. Australia Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 305. Australia Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 306. Australia Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 307. Australia Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 308. South Korea Neonatal Genetic Disease Diagnosis Market Size, 2017-2032 (USD Million)
TABLE 309. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Technology, 2017-2032 (USD Million)
TABLE 310. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Microarrays, 2017-2032 (USD Million)
TABLE 311. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Pcr, 2017-2032 (USD Million)
TABLE 312. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Sequencing, 2017-2032 (USD Million)
TABLE 313. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Disease Type, 2017-2032 (USD Million)
TABLE 314. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Testing Mode, 2017-2032 (USD Million)
TABLE 315. South Korea Neonatal Genetic Disease Diagnosis Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 316. South Korea Neonatal Genetic Disease Diagnosis Market Size, by End User, 2017-2032 (USD Million)
TABLE 317. Global Neonatal Genetic Disease Diagnosis Market Share, by Key Player, 2025
TABLE 318. Global Neonatal Genetic Disease Diagnosis Market, Key Experts

Companies Mentioned

  • Agilent Technologies, Inc.
  • Baylor Genetics
  • BGI Genomics Co., Ltd.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd.
  • Fulgent Genetics, Inc.
  • GeneDx Holdings Corp.
  • Guardant Health, Inc.
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Natera, Inc.
  • Oxford Nanopore Technologies plc
  • Personalis, Inc.
  • Quest Diagnostics Incorporated
  • Sophia Genetics SA
  • The Children's Hospital of Philadelphia
  • Thermo Fisher Scientific Inc.
  • Twist Bioscience Corporation

Related Topics

Related Reports

Pediatric and Neonatal Testing Kit Market Outlook 2025-2034: Market Share, and Growth Analysis - Product Image

Pediatric and Neonatal Testing Kit Market Outlook 2025-2034: Market Share, and Growth Analysis

  • Report
  • 160 Pages
  • Global
From
Phototherapy Machine for Neonatal Jaundice Market - Global Forecast 2026-2032 - Product Image

Phototherapy Machine for Neonatal Jaundice Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Neonatal Stethoscope Market - Global Forecast 2026-2032 - Product Image

Neonatal Stethoscope Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Pediatric and Neonatal Testing Kit Market Report 2026 - Product Image

Pediatric and Neonatal Testing Kit Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Neonatal Infant Care Market Report: Trends, Forecast and Competitive Analysis to 2031 - Product Image

Neonatal Infant Care Market Report: Trends, Forecast and Competitive Analysis to 2031

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.